HomeClinical TopicsFDA approves new drugs

FDA approves new drugs

  • On Sept. 2, the U.S. Food and Drug Administration (FDA) approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting. Read more.
  • On Aug. 27, the FDA approved Repatha (evolocumab) injection for some patients who are unable to control their low-density lipoprotein (LDL) cholesterol with current treatment options. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Couple talking to NP

Getting Covid Vaccine Won’t Hurt Pregnancy Chances; Getting Covid Could

Couples planning a pregnancy might be relieved to know that getting a Covid vaccine does not hurt their odds of conceiving, according to the...